Abbott India’s shares surged by 3% following the company’s impressive financial results for Q3. As of 1:41 PM, the shares were trading 3.24% higher at Rs 26,970.60.
The company posted a 16% year-on-year increase in net profit, reaching ₹360.8 crore compared to ₹311 crore in the same period last year.
Revenue for the quarter rose by 12.3%, totaling ₹1,614.3 crore, up from ₹1,437 crore in Q3 of the previous year. The strong revenue growth reflects the company’s robust product portfolio and increasing demand across various healthcare segments.
EBITDA also showed a positive performance, rising 12.5% to ₹436.2 crore from ₹387.7 crore year-on-year. This growth in EBITDA was supported by effective cost management and operational efficiency.
However, the company’s EBITDA margin remained stable at 27%, maintaining consistency despite the increased revenue and profit.
Abbott India shares opened at ₹26,300.00, reaching a high of ₹27,165.00 and a low of ₹26,026.05 during the trading session. The stock’s 52-week high stands at ₹30,668.00, while its 52-week low is ₹25,200.00.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
